B-CELL LYMPHOMA RECURRENT
Clinical trials for B-CELL LYMPHOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOMA RECURRENT trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Gene-Modified immune cells take on tough lymphoma
Disease control Recruiting nowThis study tests a new treatment called TranspoCART19 for people with B-cell lymphoma that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, which are genetically modified to better recognize and attack cancer cells. The trial wi…
Matched conditions: B-CELL LYMPHOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Disease control
Last updated Jun 23, 2026 22:18 UTC
-
New hope for brain lymphoma: drug combo targets tough cases
Disease control Recruiting nowThis study tests a drug called selinexor combined with chemotherapy in 37 adults with B-cell lymphoma that has come back or not responded to treatment and has spread to the brain. The goal is to find the safest dose and see if the combination can shrink tumors. Selinexor works by…
Matched conditions: B-CELL LYMPHOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 23, 2026 11:59 UTC
-
Engineered immune cells take on Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase study tests a personalized therapy where a patient's own immune cells are modified to recognize and attack cancer cells. It is for children and adults with certain blood cancers (like leukemia or lymphoma) that have not responded to standard treatments. The goal …
Matched conditions: B-CELL LYMPHOMA RECURRENT
Phase: PHASE1 • Sponsor: Nelson Hamerschlak • Aim: Disease control
Last updated Jun 22, 2026 12:08 UTC